First Trust VL Dividend (FVD)
Live price chart, market sentiment, and community perspectives for First Trust VL Dividend (AMEX: FVD).
Live price chart, market sentiment, and community perspectives for First Trust VL Dividend (AMEX: FVD).
On our desk, we are monitoring FVD's recent approach to its historical highs around $50.23. Even though the broader multi-year trajectory looks constructive with a solid large-cap low-volatility factor score, the recent formation of a potential bearish Doji combined with a Slow Stochastic reading in overbought ground suggests we might see near-term consolidation before any fresh upside breakout.
Reviewing the fund flows data, it's striking to see roughly $1.60 billion exiting FVD over the past year despite total assets under management remaining resilient around $8.1 billion. This divergence between structural AUM stability and net negative 1-year flows warrants careful monitoring of institutional sentiment regarding its 0.62% expense ratio.
When evaluating FVD's passive physical replication strategy tracking the Value Line Dividend Index, our quantitative approach highlights its extreme active share relative to the SandP 500 at 100%. With 193 holdings and top individual weights tightly capped around 0.5% (such as Entergy, Rio Tinto, and Sanofi), concentration risk remains exceptionally low, making it a defensive pillar.
Looking at the fundamental factor reports, FVD functions primarily as a large-cap low-volatility proxy with a median market cap near $36.2 billion. Analysts building multi-factor rotation models should note its balanced distribution across global large caps, spanning utilities, materials, healthcare, and financials evenly without outsized single-stock exposure.
From a risk management standpoint, the option implied volatility curves and ATM IV term structure across upcoming expiration months like July and August offer clean parameters for constructing delta-hedged overlays if the recent short-term momentum stalls near the $48.50 resistance shelf.
Explore plasma cleansing, somatic organ swaps, and BCI.